EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide

Laerke S Gasbjerg iD, Mette M Rosenkilde iD, Juris J Meier iD, Jens J Holst iD, Filip K Knop iD

Diabetes, Obesity and Metabolism · 2023

DOI: 10.1111/dom.15216 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, 2023. Verfasst von Laerke S Gasbjerg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Incretins, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 133 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tirzepatide is a unimolecular co‐agonist of the glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP) receptors recently approved for the treatment of type 2 diabetes by the US Food and Drug Administration and the European Medicine Agency. Tirzepatide treatment results in an unprecedented improvement of glycaemic control and lowering of body weight, but the contribution of the GIP receptor‐activating component of tirzepatide to these effects is uncertain. In this review, we present the current knowledge about the physiological roles of the incretin hormones GLP‐1 and GIP, their receptors, and previous results of co‐targeting the two incretin hormone receptors in humans. We also analyse the molecular pharmacological, preclinical and clinical effects of tirzepatide to discuss the role of GIP receptor activation for the clinical effects of tirzepatide. Based on the available literature on the combination of GLP‐1 and GIP receptor activation, tirzepatide does not seem to have a classical co‐activating mode of action in humans. Rather, in vitro studies of the human GLP‐1 and GIP receptors reveal a biased GLP‐1 receptor activation profile and GIP receptor downregulation. Therefore, we propose three hypotheses for the mode of action of tirzepatide, which can be addressed in future, elaborate clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IncretinsDiabetes Mellitus, Type 2HumansGlucagonBlood GlucoseGastric Inhibitory PolypeptideGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorTirzepatideReceptors, Gastrointestinal Hormone

Stichwörter der Autor:innen

GIPGLP-1antidiabetic drugantiobesity druginsulin secretionpharmacodynamics

Substanzen

IncretinsGlucagonBlood GlucoseGastric Inhibitory PolypeptideGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorTirzepatidegastric inhibitory polypeptide receptorReceptors, Gastrointestinal Hormone

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
  • Department of Internal Medicine, Gastroenterology and Diabetology, Augusta Clinic, Bochum, Germany.
  • The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Laerke S Gasbjerg, Mette M Rosenkilde, Juris J Meier, Jens J Holst, Filip K Knop

Zitieren

APA

Gasbjerg, L. S., Rosenkilde, M. M., Meier, J. J., Holst, J. J., & Knop, F. K. (2023). The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15216

Vancouver

Gasbjerg LS, Rosenkilde MM, Meier JJ, Holst JJ, Knop FK. The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide. Diabetes, Obesity and Metabolism. 2023. doi:10.1111/dom.15216

BibTeX
@article{Gasbjerg2023,
  author = {Gasbjerg, Laerke S and Rosenkilde, Mette M and Meier, Juris J and Holst, Jens J and Knop, Filip K},
  title = {The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2023},
  doi = {10.1111/dom.15216}
}
Kostenlos starten →